Bank of New York Mellon
DRUG

Bank of New York Mellon’s Bright Minds Biosciences DRUG Stock Holding History

Bank of New York Mellon’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
14,902
+1,649
+12% +$129K ﹤0.01% 3329
2026
Q1 		$967K Buy
13,253
+3,264
+33% +$263K ﹤0.01% 3228
2025
Q4 		$780K Sell
9,989
-83
-0.8% -$5.55K ﹤0.01% 3381
2025
Q3 		$611K Buy
10,072
+1,370
+16% +$53.2K ﹤0.01% 3486
2025
Q2 		$227K Buy
+8,702
New +$261K ﹤0.01% 3934

Other funds holding DRUG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Bank of New York Mellon's DRUG Position: Q2 2026 in Review

Bank of New York Mellon increased its Bright Minds Biosciences (DRUG) stake by 12% in Q2 2026, buying an estimated $129K and bringing the position to 14,902 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3329.

Bank of New York Mellon first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. 21 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Bank of New York Mellon held 14,902 shares of Bright Minds Biosciences worth $1.05M as of Q2 2026.
  • Bank of New York Mellon bought 1,649 Bright Minds Biosciences shares in Q2 2026, an estimated $129K.
  • Bright Minds Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3329 holding.
  • Bank of New York Mellon first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 21 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.